Patent details

EP1755650 Title: A biomolecule-containing suspension formulation of increased stability deliverable via an implantable delivery device.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1755650
WO Application Number:
US2005017914
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP05753131.1
WO Publication Number:
WO2005115333
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
23/05/2005
Grant date:
09/07/2008
EP Publication Date:
09/07/2008
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/12/2010
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
09/07/2008
EP B1 Publication Date:
09/07/2008
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
22/05/2025
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
09/07/2008
 
 

 

Name:
Intarcia Therapeutics, Inc.
Address:
24650 Industrial Blvd., 94545, Emeryville, California, United States of America (US)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
09/07/2008
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Gunjan JUNNARKAR
Address:
94303, Palo Alto, California, United States of America (US)

2

Name:
Michael A. DESJARDIN
Address:
CA 94087, Sunnyvale, United States of America (US)

3

Name:
Kui LIU
Address:
CA 94065, Redwood City, United States of America (US)

4

Name:
Zengji LI
Address:
CA 94583, San Ramon, United States of America (US)

Priority

1

Priority Patent Number:
650226 P
Priority Date:
03/02/2005
Priority Country:
United States of America (US)

2

Priority Patent Number:
574662 P
Priority Date:
25/05/2004
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 38/21;
IPC or IDT classification:
A61K 9/00; A61K 9/16; A61K 47/18;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
2010/42
Publication date:
08/12/2010
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
2009/01
Publication date:
05/01/2009
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
2008/09
Publication date:
01/09/2008
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
200828
Publication date:
09/07/2008
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
24/05/2009
Last Annual Fee Paid Number:
5
Last Annual Fee Paid Amount:
100 Euro
Payer:
Computer Packages Inc.
Filing date Document type Document Description Number of pages File Type
06/10/2008 Outgoing Correspondence Outgoing Letter 1 PDF /1/3/1/3/5/0505753131/docs/ep05753131.1_0_outgoingcorrespondence20081006.pdf
06/10/2008 Claims Translated claims 4 PDF /1/3/1/3/5/0505753131/docs/ep05753131.1_1_claims20081006.pdf
06/10/2008 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /1/3/1/3/5/0505753131/docs/ep05753131.1_2_incomingcorrespondencepaper20081006.pdf
28/08/2008 Incoming Correspondence Paper Correspondence address details 1 PDF /1/3/1/3/5/0505753131/docs/ep05753131.1_3_incomingcorrespondencepaper20080828.pdf